+36.1%
MRNA vs SRE
+28.3%
+7.8%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SRE | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -0.8% | +6.2% | +5.4% |
| 7D | -1.1% | -0.8% | -0.3% | -1.1% |
| 30D | +126.1% | -3.0% | +129.1% | +125.1% |
| 3M | +190.0% | -8.3% | +198.3% | +193.3% |
| 6M | +157.2% | -8.9% | +166.1% | +160.1% |
| YTD | +388.2% | -4.3% | +392.5% | +384.6% |
| 1Y | +467.0% | +2.7% | +464.3% | +450.8% |
| 3Y | +36.1% | +28.7% | +7.4% | +12.5% |
| All | +36.1% | +28.3% | +7.8% | +12.5% |
Cumulative growth
Daily Returns
Daily percentage return beside SRE.
Daily Out/Under-Performance
Portfolio return minus SRE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SRE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SRE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling